Arca Biopharma reported $54.42M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19322M 802M
Arca Biopharma ABIO:US $ 54.42M 14.31M
Biogen BIIB:US $ 9740.9M 1825M
Brainstorm Cell Therapeutics BCLI:US $ 12.81M 6.45M
Bristol Myers Squibb BMY:US $ 30186M 65M
Capricor Therapeutics CAPR:US $ 52.62M 7.01M
Cytokinetics CYTK:US $ 602.25M 21.28M
Cytrx CYTR:US 6.18M 2.1M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 5418.8B 2520B
Laboratory Of America LH:US $ 5030.8M 198.7M
Myriad Genetics MYGN:US $ 367.1M 60.3M
Otsuka Holdings 4578:JP Y 1152178M 86282M
United Therapeutics UTHR:US $ 2684.3M 97.7M